CD8A and neoplasm: Therefore, we compared the characteristics of the TIME between clusters A and B. We observed enrichment of tumor-suppressing immune cells such as CD8+ T effector cells in the Cluster A subtype, whereas, pro-tumorigenic pathways such as EMT were enriched in the Cluster B subtype.